HUPO 2021 World Congress

ABOUT HUPO

Get to Know the Speakers

Meet the speakers for the HUPO ReCONNECT 2021. In order to learn more about each individual speaker, please click on the photos below.

Pre-Congress Speakers

Ms. Maike Langini

Categories: Pre Congress Speakers
Ms. Maike Langini: United Kingdom

Currently, Maike is working at Medicines Discovery Catapult on a collaborative study with LifeArc focused on applying mass spectrometry-based proteomics in the field of drug discovery. She is finishing her PhD in chemistry at the Heinrich Heine University Düsseldorf with Prof Kai Stühler. Previous research focused on lncRNA based perturbations of protein signatures in brain tumours, secretome analysis in cancer cell lines, tumour tissue proteomics and phospho-proteomics.
Since 2017, Maike has been working with the Young Proteomics Investigators Club (YPIC) the early career researcher group of EuPA and was elected as their president in 2020.

Ms. Maike Langini

Click To Read Bio

Assoc. Prof. Cheng Chang

Categories: Pre Congress Speakers
Assoc. Prof. Cheng Chang: China

Cheng Chang received his B.E. in Electronic Engineering from Hunan University, China, in 2010 and received in his Ph.D. in Bioinformatics from Beijing Proteome Research Center, China, in 2015. Currently, he is an associate research fellow in Department of Biomedical Big Data, Beijing Proteome Research Center and National Center for Protein Sciences, Beijing. His major research interests include proteomics, bioinformatics, and precision medicine.

Assoc. Prof. Cheng Chang

Click To Read Bio

Mr. Andreas Hober

Categories: Pre Congress Speakers
Mr. Andreas Hober: Sweden

Andreas Hober graduated from KTH Royal Institute of Technology in 2017 with a Master of Science in Engineering and was awarded the Honnörsstipendium (Best Graduate of the Year), within the Biotechnology programme. He is currently enrolled as a PhD student in the group of Targeted Proteomics at KTH Royal Institute of Technology, headed by Prof. Mathias Uhlén

Andreas Hober’s research is centered around development of targeted proteomics methods for more sensitive assays. His focus is on developing precise quantification for clinically relevant protein targets in human blood plasma to be used for precision medicine applications. Within this area, an assay for monitoring the levels of apolipoproteins in clinical cohorts has already been implemented and a SISCAPA-based method for SARS-CoV-2 diagnostics been developed. The current goal is to continue this path and develop assays for monitoring low abundant FDA approved protein targets by using affinity reagents.

Mr. Andreas Hober

Click To Read Bio

Prof. Jennifer Geddes-McAlister

Categories: Pre Congress Speakers
Prof. Jennifer Geddes-McAlister: Canada

Dr. Jennifer Geddes-McAlister completed her PhD from the University of British Columbia (Canada) under the supervision of Dr. Jim Kronstad focusing on the impact of signal transduction cascades in the human fungal pathogen, Cryptococcus neoformans. She reported the first biomarkers of cryptococcal infection and discovered a novel drug-repurposing strategy to treat cryptococcosis. She then went on to pursue a post-doctoral fellowship funded through the Alexander von Humboldt Foundation at the Max Planck Institute of Biochemistry (Germany) under the guidance of Prof. Dr. Matthias Mann, world renowned leader in mass spectrometry-based proteomics. In July 2018, Dr. Geddes-McAlister started her own research group at the University of Guelph (Canada) where her research team explores the intricate relationships between pathogen and host during infection from a systems biology perspective with both medical and agricultural relevance. She currently manages a lab of 25 trainees with diverse funding and industry partnerships to advance our knowledge of infection and propose new treatment strategies.

Prof. Jennifer Geddes-McAlister

Click To Read Bio

Prof. Marc Wilkins

Categories: Pre Congress Speakers
Prof. Marc Wilkins: Australia

In 1994, Marc Wilkins developed the concept of the proteome and coined the term. He has since published >220 peer-reviewed research papers, review papers and book chapters in the fields of proteomics, genomics / transcriptomics and in systems biology. In proteomics, he has a focus on the functional analysis and regulation of protein methylation.

In industry, Wilkins has co-founded two biotechnology companies. Proteome Systems Ltd, established in 1999, developed proteomics technology and a platform for rapid point-of-care diagnostic testing. Regeneus Pty Ltd, established in 2007, has pioneered the clinical use of adult stem cells to treat a range of musculoskeletal disorders.

Wilkins has been elected to the council of HUPO four times, is a current council member, and was program chair of HUPO2010 (Sydney) and a co-organiser of HUPO2019 (Adelaide). He serves on of the management committee of the Australian Proteomics Society and is a co-organiser of its annual conference.

Prof. Marc Wilkins

Click To Read Bio

Prof. Anne-Claude Gingras

Categories: Pre Congress Speakers
Prof. Anne-Claude Gingras: Canada

Anne-Claude Gingras is the Canada Research Chair in Functional Proteomics and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health. A Professor of Molecular Genetics (University of Toronto), she also serves as deputy editor of Molecular and Cellular Proteomics. She focuses on the study of signalling pathways using systematic approaches and the development of quantitative proteomics technologies, including for analysis and visualization of proteomics results. Her group has identified new protein complexes and signaling components that provide a better understanding of perturbations associated with cancer and rare diseases. Dr. Gingras has published >250 research and review articles that have already been cited >43,000 times. She is a Fellow of the Royal Society of Canada, an elected member of the European Molecular Biology Organization (EMBO) and was recently awarded the CSMB Jeanne Manery Fisher Memorial Lecture (2019), the HUPO Discovery Award (2019), and the CNPN Tony Pawson Award (2020).

Prof. Anne-Claude Gingras

Click To Read Bio

Dr. Isabell Bludau

Categories: Pre Congress Speakers
Dr. Isabell Bludau: Germany

Isabell Bludau is a postdoctoral fellow in the lab of Prof. Matthias Mann at the Max Planck Institute of Biochemistry near Munich. During her PhD with Prof. Ruedi Aebersold at the Institute of Molecular Systems Biology, ETH Zurich, Isabell developed computational methods for analysing large-scale proteomics data. She specifically focused on the detection and quantification of protein complexes. Recently, Isabell’s work focuses on the inference of different proteoforms and their crosstalk. Isabell’s PhD thesis was awarded with the ETH silver medal and her postdoctoral research is supported by a Postdoc.Mobility fellowship of the Swiss National Science Foundation.

Dr. Isabell Bludau

Click To Read Bio

Prof. Lieven Clement

Categories: Pre Congress Speakers
Prof. Lieven Clement: Belgium

Lieven Clement is an Associate Professor of Statistical Genomics at Ghent University. He is an expert in developing statistical methods and open source tools for differential omics data analysis. His research efforts resulted in numerous publications on novel methods and tools for, and applied research in omics data analysis.

His lab is built around two strategic research pillars each connected to an omics domain: (single cell) transcriptomics and proteomics and he also has a strong interest in leveraging his expertise to translational research.

Prof. Lieven Clement

Click To Read Bio

Prof. David Tabb

Categories: Pre Congress Speakers
Prof. David Tabb: France

David Tabb began work in proteome informatics in 1996, when he began Ph.D. training with the John Yates lab. Twenty-five years later, he has gained experience in challenges ranging from proteomic database search to identification of phospholipids. After moving to South Africa in 2015 and to France in 2021, he has found great joy in training other scientists, ranging from B.Sc. Honours students to post-doctoral researchers. Many of his training lectures can be found through his blog site: https://pickingupthetabb.wordpress.com/

Prof. David Tabb

Click To Read Bio

Dr. Lindsay Pino

Categories: Pre Congress Speakers
Dr. Lindsay Pino: United States

Lindsay has over a decade of experience in developing mass spectrometry proteomics methods for studying human disease. She has trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania. Her focus is on developing techniques for quantitative proteomics, with a particular interest in the challenges associated with scaling-up quantitative proteomics experiments.

Dr. Lindsay Pino

Click To Read Bio

Dr. Yves Vandenbrouck

Categories: Pre Congress Speakers
Dr. Yves Vandenbrouck: France

Dr. Yves Vandenbrouck has been working at the BioHealth Department (CEA, University of Grenoble, FR) as PI, in close collaboration with both a proteomics infrastructure, data scientists and biologists/clinicians. His research interests focuses on the design of bioinformatics tools and strategies to leverage the ever-increasing wealth and diversity of “omics” data for biomarkers discovery and the elucidation of biological processes underlying human diseases (orcid: 0000-0002-1292-373X). For many years, Yves has been active in the HUPO community by contributing to the Human Proteome Project and as a co-founder of the “Bioinformatics Hub”. He is also involved in community efforts such as the European Elixir proteomics initiative, which aims at disseminating proteomics data analysis pipelines, and the “Galaxy for Mass Spectrometry” workgroup. During this session, Yves will introduce ProteoRE, a Galaxy-based instance for the interpretation of proteomics data for biomedical research.

Dr. Yves Vandenbrouck

Click To Read Bio

Dr. Mikhail Savitski

Categories: Pre Congress Speakers
Dr. Mikhail Savitski: Germany

Mikhail Savitski studied mathematics and physics at Uppsala University, where he also did his PhD in ion physics/mass spectrometry. After his PhD he worked at Cellzome as Group Leader in the Analytical Sciences department. Since 2016 he works at EMBL heading a research group as well as the proteomics core facility. He develops novel proteomics technologies and uses them to study post-translational regulation. He is an author of 90 peer reviewed publications including corresponding author papers in Nature, Cell, Science.

Dr. Mikhail Savitski

Click To Read Bio

Prof. Michael MacCoss

Categories: Pre Congress Speakers
Prof. Michael MacCoss: United States

Michael MacCoss has been working with mass spectrometry instrumentation since 1994 when he was an undergraduate in a stable isotope geochemistry lab at the University of Vermont. He became interested in biomedical applications working in Dr. Patrick Griffin’s protein mass spectrometry lab at Merck Research Laboratories during two summer internships in 1995 and 1996. In 2001, he completed a Ph.D. in Analytical Chemistry with Professor Dwight Matthews in the development of stable isotope and mass spectrometry methodologies for the measurement of human amino acid and protein metabolism. After completing his degree, Dr. MacCoss moved to The Scripps Research Institute to work with the proteomics pioneer John R. Yates III as a postdoctoral fellow. During his postdoctoral training, Dr. MacCoss worked on methodology and software for many areas of proteomics, ranging from the improved characterization of post-translational modifications and the quantitative analysis of complex protein mixtures. Dr. MacCoss moved to the University of Washington in 2004 as an Assistant Professor of Genome Sciences and was promoted to Professor in 2014. At the University of Washington, his lab has focused on the development and application of mass spectrometry based technologies for the high throughput characterization of complex protein mixtures. Realizing that software was a major limitation in proteomics, Dr. MacCoss has established a major software engineering effort within his group at the University of Washington. Their laboratory’s software is noted for its robustness, versatility and user friendliness. Dr. MacCoss and his team continually work to improve their tools, provide documentation, and a community around their software. In 2007 he was the recipient of a Presidential Award for Scientists and Engineers (PECASE). He was selected to receive the Biemann Medal from the American Society for Mass Spectrometry and the 2016 HUPO Award for Discovery in Proteomics Sciences. The MacCoss lab’s research has been at the intersection of biochemistry, instrumentation, engineering, computer science, and statistics.

Prof. Michael MacCoss

Click To Read Bio

Dr. Juergen Cox

Categories: Pre Congress Speakers
Dr. Juergen Cox: Germany

Juergen Cox is a Research Group Leader at the Max Planck Institute for Biochemistry in Martinsried where he heads the Lab for Computational Systems Biochemistry. He received his PhD in physics at the Massachusetts Institute of Technology and has since developed MaxQuant, a quantitative proteomics software package designed for analyzing large mass spectrometric data sets. Dr. Cox is the author of numerous peerreviewed publications in the field of data analysis in mass spectrometry and quantitative proteomics.

Dr. Juergen Cox

Click To Read Bio

Dr. Edward Huttlin

Categories: Pre Congress Speakers
Dr. Edward Huttlin: United States

Ed Huttlin is an Instructor in the Department of Cell Biology at Harvard Medical School, where he oversees the BioPlex project– a longstanding effort to profile protein-protein interactions in human cells via affinity-purification mass spectrometry (bioplex.hms.harvard.edu)– as co-Principal Investigator along with Professors Steve Gygi and Wade Harper. In this capacity, Ed is responsible for all aspects of quality control, data analysis, and dissemination.

Although his recent work is heavily computational, Ed earned his PhD in Biochemistry at the University of Wisconsin, Madison, working in the lab of Professor Michael Sussman on quantitative proteomics applications of in vivo 15N metabolic labeling in organisms ranging from Arabidopsis to mice. He then joined the lab of Steve Gygi at Harvard where he has participated in development of isobaric labeling technology and led an effort to profile protein expression and phosphorylation across nine mouse tissues prior to assuming responsibility for the BioPlex project.

Dr. Edward Huttlin

Click To Read Bio

Dr. Brian Searle

Categories: Pre Congress Speakers
Dr. Brian Searle: United States

Brian Searle is an Assistant Professor at the Ohio State University Medical Center in the Department of Biomedical Informatics and a member of the Pelotonia Institute for Immuno-Oncology. Brian received his chemistry BA at Reed College in 2001. In 2004, he co-founded Proteome Software with Mark Turner and Dr. Ashley McCormack to produce and distribute cutting-edge data analysis software for proteomicists. In 2014, he returned to academia to earn his PhD with Dr. Michael MacCoss at University of Washington, where he developed methods to detect and quantify proteins and phosphosites using mass spectrometry. His lab spans the intersection of proteomics, mass spectrometry, bioinformatics, and technology development to study human genetic variation in the backdrop of cancer.

Dr. Brian Searle

Click To Read Bio

Main Congress Speakers

Ms. Maike Langini

Categories: Pre Congress Speakers
Ms. Maike Langini: United Kingdom

Currently, Maike is working at Medicines Discovery Catapult on a collaborative study with LifeArc focused on applying mass spectrometry-based proteomics in the field of drug discovery. She is finishing her PhD in chemistry at the Heinrich Heine University Düsseldorf with Prof Kai Stühler. Previous research focused on lncRNA based perturbations of protein signatures in brain tumours, secretome analysis in cancer cell lines, tumour tissue proteomics and phospho-proteomics.
Since 2017, Maike has been working with the Young Proteomics Investigators Club (YPIC) the early career researcher group of EuPA and was elected as their president in 2020.

Ms. Maike Langini

Click To Read Bio

Assoc. Prof. Cheng Chang

Categories: Pre Congress Speakers
Assoc. Prof. Cheng Chang: China

Cheng Chang received his B.E. in Electronic Engineering from Hunan University, China, in 2010 and received in his Ph.D. in Bioinformatics from Beijing Proteome Research Center, China, in 2015. Currently, he is an associate research fellow in Department of Biomedical Big Data, Beijing Proteome Research Center and National Center for Protein Sciences, Beijing. His major research interests include proteomics, bioinformatics, and precision medicine.

Assoc. Prof. Cheng Chang

Click To Read Bio

Mr. Andreas Hober

Categories: Pre Congress Speakers
Mr. Andreas Hober: Sweden

Andreas Hober graduated from KTH Royal Institute of Technology in 2017 with a Master of Science in Engineering and was awarded the Honnörsstipendium (Best Graduate of the Year), within the Biotechnology programme. He is currently enrolled as a PhD student in the group of Targeted Proteomics at KTH Royal Institute of Technology, headed by Prof. Mathias Uhlén

Andreas Hober’s research is centered around development of targeted proteomics methods for more sensitive assays. His focus is on developing precise quantification for clinically relevant protein targets in human blood plasma to be used for precision medicine applications. Within this area, an assay for monitoring the levels of apolipoproteins in clinical cohorts has already been implemented and a SISCAPA-based method for SARS-CoV-2 diagnostics been developed. The current goal is to continue this path and develop assays for monitoring low abundant FDA approved protein targets by using affinity reagents.

Mr. Andreas Hober

Click To Read Bio

Prof. Jennifer Geddes-McAlister

Categories: Pre Congress Speakers
Prof. Jennifer Geddes-McAlister: Canada

Dr. Jennifer Geddes-McAlister completed her PhD from the University of British Columbia (Canada) under the supervision of Dr. Jim Kronstad focusing on the impact of signal transduction cascades in the human fungal pathogen, Cryptococcus neoformans. She reported the first biomarkers of cryptococcal infection and discovered a novel drug-repurposing strategy to treat cryptococcosis. She then went on to pursue a post-doctoral fellowship funded through the Alexander von Humboldt Foundation at the Max Planck Institute of Biochemistry (Germany) under the guidance of Prof. Dr. Matthias Mann, world renowned leader in mass spectrometry-based proteomics. In July 2018, Dr. Geddes-McAlister started her own research group at the University of Guelph (Canada) where her research team explores the intricate relationships between pathogen and host during infection from a systems biology perspective with both medical and agricultural relevance. She currently manages a lab of 25 trainees with diverse funding and industry partnerships to advance our knowledge of infection and propose new treatment strategies.

Prof. Jennifer Geddes-McAlister

Click To Read Bio

Prof. Marc Wilkins

Categories: Pre Congress Speakers
Prof. Marc Wilkins: Australia

In 1994, Marc Wilkins developed the concept of the proteome and coined the term. He has since published >220 peer-reviewed research papers, review papers and book chapters in the fields of proteomics, genomics / transcriptomics and in systems biology. In proteomics, he has a focus on the functional analysis and regulation of protein methylation.

In industry, Wilkins has co-founded two biotechnology companies. Proteome Systems Ltd, established in 1999, developed proteomics technology and a platform for rapid point-of-care diagnostic testing. Regeneus Pty Ltd, established in 2007, has pioneered the clinical use of adult stem cells to treat a range of musculoskeletal disorders.

Wilkins has been elected to the council of HUPO four times, is a current council member, and was program chair of HUPO2010 (Sydney) and a co-organiser of HUPO2019 (Adelaide). He serves on of the management committee of the Australian Proteomics Society and is a co-organiser of its annual conference.

Prof. Marc Wilkins

Click To Read Bio

Prof. Anne-Claude Gingras

Categories: Pre Congress Speakers
Prof. Anne-Claude Gingras: Canada

Anne-Claude Gingras is the Canada Research Chair in Functional Proteomics and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health. A Professor of Molecular Genetics (University of Toronto), she also serves as deputy editor of Molecular and Cellular Proteomics. She focuses on the study of signalling pathways using systematic approaches and the development of quantitative proteomics technologies, including for analysis and visualization of proteomics results. Her group has identified new protein complexes and signaling components that provide a better understanding of perturbations associated with cancer and rare diseases. Dr. Gingras has published >250 research and review articles that have already been cited >43,000 times. She is a Fellow of the Royal Society of Canada, an elected member of the European Molecular Biology Organization (EMBO) and was recently awarded the CSMB Jeanne Manery Fisher Memorial Lecture (2019), the HUPO Discovery Award (2019), and the CNPN Tony Pawson Award (2020).

Prof. Anne-Claude Gingras

Click To Read Bio

Dr. Isabell Bludau

Categories: Pre Congress Speakers
Dr. Isabell Bludau: Germany

Isabell Bludau is a postdoctoral fellow in the lab of Prof. Matthias Mann at the Max Planck Institute of Biochemistry near Munich. During her PhD with Prof. Ruedi Aebersold at the Institute of Molecular Systems Biology, ETH Zurich, Isabell developed computational methods for analysing large-scale proteomics data. She specifically focused on the detection and quantification of protein complexes. Recently, Isabell’s work focuses on the inference of different proteoforms and their crosstalk. Isabell’s PhD thesis was awarded with the ETH silver medal and her postdoctoral research is supported by a Postdoc.Mobility fellowship of the Swiss National Science Foundation.

Dr. Isabell Bludau

Click To Read Bio

Prof. Lieven Clement

Categories: Pre Congress Speakers
Prof. Lieven Clement: Belgium

Lieven Clement is an Associate Professor of Statistical Genomics at Ghent University. He is an expert in developing statistical methods and open source tools for differential omics data analysis. His research efforts resulted in numerous publications on novel methods and tools for, and applied research in omics data analysis.

His lab is built around two strategic research pillars each connected to an omics domain: (single cell) transcriptomics and proteomics and he also has a strong interest in leveraging his expertise to translational research.

Prof. Lieven Clement

Click To Read Bio

Prof. David Tabb

Categories: Pre Congress Speakers
Prof. David Tabb: France

David Tabb began work in proteome informatics in 1996, when he began Ph.D. training with the John Yates lab. Twenty-five years later, he has gained experience in challenges ranging from proteomic database search to identification of phospholipids. After moving to South Africa in 2015 and to France in 2021, he has found great joy in training other scientists, ranging from B.Sc. Honours students to post-doctoral researchers. Many of his training lectures can be found through his blog site: https://pickingupthetabb.wordpress.com/

Prof. David Tabb

Click To Read Bio

Dr. Lindsay Pino

Categories: Pre Congress Speakers
Dr. Lindsay Pino: United States

Lindsay has over a decade of experience in developing mass spectrometry proteomics methods for studying human disease. She has trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania. Her focus is on developing techniques for quantitative proteomics, with a particular interest in the challenges associated with scaling-up quantitative proteomics experiments.

Dr. Lindsay Pino

Click To Read Bio

Dr. Yves Vandenbrouck

Categories: Pre Congress Speakers
Dr. Yves Vandenbrouck: France

Dr. Yves Vandenbrouck has been working at the BioHealth Department (CEA, University of Grenoble, FR) as PI, in close collaboration with both a proteomics infrastructure, data scientists and biologists/clinicians. His research interests focuses on the design of bioinformatics tools and strategies to leverage the ever-increasing wealth and diversity of “omics” data for biomarkers discovery and the elucidation of biological processes underlying human diseases (orcid: 0000-0002-1292-373X). For many years, Yves has been active in the HUPO community by contributing to the Human Proteome Project and as a co-founder of the “Bioinformatics Hub”. He is also involved in community efforts such as the European Elixir proteomics initiative, which aims at disseminating proteomics data analysis pipelines, and the “Galaxy for Mass Spectrometry” workgroup. During this session, Yves will introduce ProteoRE, a Galaxy-based instance for the interpretation of proteomics data for biomedical research.

Dr. Yves Vandenbrouck

Click To Read Bio

Dr. Mikhail Savitski

Categories: Pre Congress Speakers
Dr. Mikhail Savitski: Germany

Mikhail Savitski studied mathematics and physics at Uppsala University, where he also did his PhD in ion physics/mass spectrometry. After his PhD he worked at Cellzome as Group Leader in the Analytical Sciences department. Since 2016 he works at EMBL heading a research group as well as the proteomics core facility. He develops novel proteomics technologies and uses them to study post-translational regulation. He is an author of 90 peer reviewed publications including corresponding author papers in Nature, Cell, Science.

Dr. Mikhail Savitski

Click To Read Bio

Prof. Michael MacCoss

Categories: Pre Congress Speakers
Prof. Michael MacCoss: United States

Michael MacCoss has been working with mass spectrometry instrumentation since 1994 when he was an undergraduate in a stable isotope geochemistry lab at the University of Vermont. He became interested in biomedical applications working in Dr. Patrick Griffin’s protein mass spectrometry lab at Merck Research Laboratories during two summer internships in 1995 and 1996. In 2001, he completed a Ph.D. in Analytical Chemistry with Professor Dwight Matthews in the development of stable isotope and mass spectrometry methodologies for the measurement of human amino acid and protein metabolism. After completing his degree, Dr. MacCoss moved to The Scripps Research Institute to work with the proteomics pioneer John R. Yates III as a postdoctoral fellow. During his postdoctoral training, Dr. MacCoss worked on methodology and software for many areas of proteomics, ranging from the improved characterization of post-translational modifications and the quantitative analysis of complex protein mixtures. Dr. MacCoss moved to the University of Washington in 2004 as an Assistant Professor of Genome Sciences and was promoted to Professor in 2014. At the University of Washington, his lab has focused on the development and application of mass spectrometry based technologies for the high throughput characterization of complex protein mixtures. Realizing that software was a major limitation in proteomics, Dr. MacCoss has established a major software engineering effort within his group at the University of Washington. Their laboratory’s software is noted for its robustness, versatility and user friendliness. Dr. MacCoss and his team continually work to improve their tools, provide documentation, and a community around their software. In 2007 he was the recipient of a Presidential Award for Scientists and Engineers (PECASE). He was selected to receive the Biemann Medal from the American Society for Mass Spectrometry and the 2016 HUPO Award for Discovery in Proteomics Sciences. The MacCoss lab’s research has been at the intersection of biochemistry, instrumentation, engineering, computer science, and statistics.

Prof. Michael MacCoss

Click To Read Bio

Dr. Juergen Cox

Categories: Pre Congress Speakers
Dr. Juergen Cox: Germany

Juergen Cox is a Research Group Leader at the Max Planck Institute for Biochemistry in Martinsried where he heads the Lab for Computational Systems Biochemistry. He received his PhD in physics at the Massachusetts Institute of Technology and has since developed MaxQuant, a quantitative proteomics software package designed for analyzing large mass spectrometric data sets. Dr. Cox is the author of numerous peerreviewed publications in the field of data analysis in mass spectrometry and quantitative proteomics.

Dr. Juergen Cox

Click To Read Bio

Dr. Edward Huttlin

Categories: Pre Congress Speakers
Dr. Edward Huttlin: United States

Ed Huttlin is an Instructor in the Department of Cell Biology at Harvard Medical School, where he oversees the BioPlex project– a longstanding effort to profile protein-protein interactions in human cells via affinity-purification mass spectrometry (bioplex.hms.harvard.edu)– as co-Principal Investigator along with Professors Steve Gygi and Wade Harper. In this capacity, Ed is responsible for all aspects of quality control, data analysis, and dissemination.

Although his recent work is heavily computational, Ed earned his PhD in Biochemistry at the University of Wisconsin, Madison, working in the lab of Professor Michael Sussman on quantitative proteomics applications of in vivo 15N metabolic labeling in organisms ranging from Arabidopsis to mice. He then joined the lab of Steve Gygi at Harvard where he has participated in development of isobaric labeling technology and led an effort to profile protein expression and phosphorylation across nine mouse tissues prior to assuming responsibility for the BioPlex project.

Dr. Edward Huttlin

Click To Read Bio

Dr. Brian Searle

Categories: Pre Congress Speakers
Dr. Brian Searle: United States

Brian Searle is an Assistant Professor at the Ohio State University Medical Center in the Department of Biomedical Informatics and a member of the Pelotonia Institute for Immuno-Oncology. Brian received his chemistry BA at Reed College in 2001. In 2004, he co-founded Proteome Software with Mark Turner and Dr. Ashley McCormack to produce and distribute cutting-edge data analysis software for proteomicists. In 2014, he returned to academia to earn his PhD with Dr. Michael MacCoss at University of Washington, where he developed methods to detect and quantify proteins and phosphosites using mass spectrometry. His lab spans the intersection of proteomics, mass spectrometry, bioinformatics, and technology development to study human genetic variation in the backdrop of cancer.

Dr. Brian Searle

Click To Read Bio

Prof. Paola Picotti

Categories: Main Congress Speakers
Prof. Paola Picotti: Switzerland

After her PhD at the University of Padua (Italy), Paola Picotti did postdoctoral research in the group of Ruedi Aebersold at ETH Zurich, where she developed targeted proteomic technologies based on mass spectrometry. In 2011, she was appointed Assistant Professor at the Institute of Biochemistry, ETHZ, and in 2017 tenured Associate Professor at the Institute of Molecular Systems Biology, ETHZ. Major contributions of the Picotti group include the development of structural proteomics technologies to probe in situ protein structural changes, characterization of the determinants of proteome thermostability, large-scale identification of protein-small molecule interactions, and the discovery of regulators of toxic proteins in Parkinson’s disease. Dr. Picotti was awarded the Latsis Prize, the Cotter Award of US HUPO, the SGMS award, the EMBO Young Investigator Award, the Friedrich Miescher Award, the Juan- Pablo Albar award of the European Proteome Association, ERC Starting and Consolidator grants, and the EMBO Gold Medal.

Prof. Paola Picotti

Click To Read Bio

Prof. Michael Snyder

Categories: Main Congress Speakers
Prof. Michael Snyder: United States

Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and multiomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor (TF) binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated (e.g. lncRNAs and TF binding sites), and a high diversity of transcription factor binding occurs both between and within species. He launched the field of personalized medicine by combining different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of a person, and his laboratory pioneered the use of wearables technologies (smart watches and continuous glucose monitoring) for precision health. He is a cofounder of many biotechnology companies, including Personalis, SensOmics, Qbio, January, Protos, Oralome, Mirvie and Filtricine.

Prof. Michael Snyder

Click To Read Bio

Prof. Ruedi Aebersold

Categories: Main Congress Speakers
Prof. Ruedi Aebersold: Switzerland

Ruedi Aebersold is a Swiss and Canadian scientist. He trained at the Biocenter, University of Basel and completed his education at Caltech. He was on the faculties of the Universities of British Columbia and Washington and co-founded, with Lee Hood and Alan Aderem, the Institute for Systems Biology in Seattle, a world first. He was a Professor at ETH Zurich and the University of Zurich from 2004 until 2020. The research focus of the Aebersold group was the proteome. Ruedi has co-founded several companies and holds several public service appointments. He was awarded an honorary doctorate of the University of Lund, Sweden and the work of the group was recognized with numerous prizes and awards. In 2020, Ruedi received the prestigious Marcel Benoist Swiss Science Prize for his pioneering work in the field of systems biology.

Prof. Ruedi Aebersold

Click To Read Bio

Assoc. Prof. Tami Geiger

Categories: Main Congress Speakers
Assoc. Prof. Tami Geiger: Isreal

Tami Geiger studied biology at the Hebrew University of Jerusalem, Israel, where she also completed her master’s and doctoral degrees in biochemistry. She carried out her Ph.D. research under the supervision of Prof. Alexander Levitzki, studying signaling changes during cancer progression. In 2008 she moved to the laboratory of Prof. Matthias Mann at the Max Planck Institute of Biochemistry to specialize in proteomics technology and to apply it to cancer research. In October 2011, Tami moved back to Israel and opened her own research laboratory at the Sackler Faculty of Medicine at the Tel Aviv University, and in 2021 she moved to the Weizmann Institute of Science. She is proceeding with clinical proteomic research of breast cancer, melanoma, ovarian and pancreatic cancer and integration with genomic analyses. She studies questions related to cancer progression, drug response, and tumor heterogeneity. In addition, Tami is the chair of the Israel Young Academy.

Assoc. Prof. Tami Geiger

Click To Read Bio

Prof. Kathryn Lilley

Categories: Main Congress Speakers
Prof. Kathryn Lilley: United Kingdom

Kathryn received her PhD in Biochemistry from the University of Sheffield. After being a laboratory manager for eleven years, she established the Cambridge Centre for Proteomics, University of Cambridge in 2001. She became the Professor in Cellular Dynamics in Department of Biochemistry University of Cambridge in 2012. She directs a research programme focused on the development and application of technologies to map RNA and protein subcellular localization on a cell-wide scale. Her research looks at the effect of post transcriptional and post translational processing on location, and the extent of relocalization in response to cellular stress and disease.
She is a recipient of a Wellcome Trust Investigator Award and a partner in EPIC-XS. She is the recipient of the Juan Pablo Albar Proteome Pioneer Award from the European Proteomics Association the HUPO Distinguished Achievements in Proteomics award. She was elected as a member of EMBO in July 2020.

Prof. Kathryn Lilley

Click To Read Bio

Prof. Fuchu He

Categories: Main Congress Speakers
Prof. Fuchu He: China

Dr. He is the leading scientist studying proteomics in China and liver proteomics in the world. He was the founder of CNHUPO and among the first group of people who founded HUPO in 2001. He was the first Chinese scientist who led an international consortium-Human Liver Proteome Project (HLPP), and the founder of Beijing Proteome Research Center, Phoenix Center (proteomics) and Institutes of Biomedical Sciences Fudan University. His team stratified early hepatocarcinoma (HCC) into 3 proteomic subtypes with different clinical outcome. Some drug targetable proteins have been demonstrated useful in identifying patients with HCC who could potentially benefit from targeted treatment in further clinical trials. These studies demonstrated the proteomic analysis as an independent powerful tool in cancer molecular subtyping, indicating that the era of “Proteome Driven Precision Medicine (PDPM)” is coming.

Prof. Fuchu He

Click To Read Bio

Assoc. Prof. Nikolai Slavov

Categories: Main Congress Speakers
Assoc. Prof. Nikolai Slavov: United States

“Nikolai Slavov’s group seeks principles in the coordination among protein synthesis, metabolism, cell growth and differentiation. The Slavov group has pioneered high-throughput mass-spectrometry methods for quantifying proteins in single cells and is developing new computational methods for analyzing and understanding single-cell proteomics and multimodal data. The group obtained direct evidence for a new regulatory mechanism of protein synthesis (ribosome specialization) and continues to drive research in this emerging field supported by the NIH Director’s New Innovator Award. Dr. Slavov studied biology and physics at MIT before completing a dissertation at Princeton University (Botstein laboratory) with research focused on the coordination among metabolism, growth and gene expression. He then returned to MIT (van Oudenaarden laboratory) for post-doctoral research that characterized trade-offs of aerobic glycolysis.

Dr. Slavov actively organizes community initiatives, such as the annual single-cell proteomics conference (single-cell.net), which is a highly interactive and interdisciplinary meeting. He also participates and contributes to organizing other leading conferences, including NeurIPS.”

Assoc. Prof. Nikolai Slavov

Click To Read Bio

Dr. Lisa Jones

Categories: Main Congress Speakers
Dr. Lisa Jones: United States

Lisa M. Jones is an Associate Professor in the Department of Pharmaceutical Sciences at the University of Maryland. She received postdoctoral training in structural virology at the University of Alabama- Birmingham and in MS-based protein footprinting at Washington University in St. Louis. Dr. Jones’s research interests include the use of the protein footprinting method fast photochemical oxidation of proteins (FPOP) coupled with mass spectrometry for the characterization of the higher order structure of proteins. In particular, her lab has further developed the FPOP method for in-cell (IC-FPOP) studies for proteome-wide structural biology. Biological applications of IC-FPOP include characterizing protein folding intermediates directly in the cell and drug target (both on and off targets) determination. The Jones lab has also extended the method for in vivo analysis (IV-FPOP) in C. elegans. This provides the ability to study protein structure in an animal model for human disease.

Dr. Lisa Jones

Click To Read Bio

Prof. Matthias Mann

Categories: Main Congress Speakers
Prof. Matthias Mann: Germany

Professor Matthias Mann obtained his Ph.D. in chemical engineering at Yale, contributing to the Nobel Prize for his supervisor John Fenn for electrospray ionization. He is a Research Director of the Proteomics and Signal Transduction department at the Max-Planck Institute of Biochemistry (Germany) and the Proteomics Program at Novo Nordisk Foundation Center for Protein Research (Denmark). He is the recipient of several prestigious honours and is the highest cited German researcher with an h-index 240 and over 275,000 citations (Google scholar). He has pioneered advances in sample preparation, chromatography, mass spectrometry and computer algorithms to make proteomics applicable to molecular biology. His team has made landmark contributions in signal transduction, biomarker discovery, and metabolic diseases and are continually developing novel proteomic methods to understand human diseases better, more recently, at single-cell resolution. His vision is to bring proteomics expertise into clinics for guiding diagnostics and prognostic decisions.

Prof. Matthias Mann

Click To Read Bio

Prof. Kun-Hsing Yu

Categories: Main Congress Speakers
Prof. Kun-Hsing Yu: United States

Kun-Hsing “Kun” Yu, MD, PhD is an Assistant Professor in the Department of Biomedical Informatics at Harvard Medical School. He integrates cancer patients’ multi-omics (genomics, epigenomics, transcriptomics, and proteomics) profiles with quantitative histopathology patterns to predict their clinical phenotypes. He developed the first fully automated algorithm to extract thousands of features from whole-slide histopathology images, discovered the molecular mechanisms underpinning the microscopic phenotypes of tumor cells, and successfully identified previously unknown cellular morphologies associated with patient prognosis. Dr. Yu’s research interests include quantitative pathology, machine learning, and pathology-multiomics data integration.

Prof. Kun-Hsing Yu

Click To Read Bio

Assoc. Prof. Teck Yew Low

Categories: Main Congress Speakers
Assoc. Prof. Teck Yew Low: Malaysia

Dr Teck Yew Low is an Associate Professor and Senior Research Fellow at the UKM Medical Molecular Biology Institute (UMBI) located in the National University of Malaysia (UKM), leading the cancer proteomics and metabolomics group. He is also the Secretary Genral of Asia-Oceania Human Proteome Organization (AOHUPO) and a Council Member for Human Proteome Organization (HUPO).

Assoc. Prof. Teck Yew Low

Click To Read Bio

Dr. Justyna Fert-Bober

Categories: Main Congress Speakers
Dr. Justyna Fert-Bober: United States

I am an Assistant Professor at Cedars-Sinai Heart Institute, and my research is focused on molecular and cellular mechanisms of heart failure (HF) in general population and in the immunopathogenesis of heart disease in the rheumatoid arthritis (RA) patient. I have a broad background in biochemistry, with specific training and expertise in proteomics and mass spectrometry and secondary immunology research. I am a pioneer in the understanding of arginine deiminases and protein citrullination’s contribution to neo-antigens production. My lab is interested in targeting the citrullinated proteins associated with the HF disease and finding the functional significance at least, in a subset of biologically important modifiable cardiac proteins. I claim that cardiac specific citrullinated proteins yield neo-antigens production and can become additional targets in epitope spreading of autoimmune responses. This will allow to create new diagnostics and prognostic tests for clinical use.

Dr. Justyna Fert-Bober

Click To Read Bio

Ms. Maurine Fucito

Categories: Main Congress Speakers
Ms. Maurine Fucito: Italy

Maurine Fucito is a Marie Skłodowska-Curie Fellow at the Center for Advanced Studies and Technology (CAST) at the University G. D’Annunzio of Chieti-Pescara, Italy. After four years at the University of Liège, Belgium and one year at the University of Aveiro, Portugal studying chemistry, she started her Ph.D. in February 2020. She is part of the PMSMatTrain project that aims at developing a novel biomaterial-based device for the treatment of progressive multiple sclerosis. Her work consists in analysing lipids and proteins alteration in multiple sclerosis like models using mass spectrometry (LC-MS/MS and MALDI-MS Imaging) to validate the therapeutic efficacy of this novel device and to better understand the disease pathophysiology. She is a core member of the Young Proteomics Investigators Club (YPIC) and she takes part of the HUPO ECR Initiative.

Ms. Maurine Fucito

Click To Read Bio

Dr. Mathieu Lavallée-Adam

Categories: Main Congress Speakers
Dr. Mathieu Lavallée-Adam: Canada

Mathieu Lavallée-Adam is an Assistant Professor at the University of Ottawa in the Department of Biochemistry, Microbiology and Immunology and at the Ottawa Institute of Systems Biology. He obtained a B.Sc. in Computer Science and a Ph.D. in Computer Science from McGill University. He then performed his postdoctoral research at Scripps Research. His research focuses on the development of statistical and machine learning algorithms for the analysis of mass spectrometry-based proteomics data and protein-protein interaction networks. He also designs computational methods mining proteomics datasets for biological information through their integration with genomics data. Dr. Lavallée-Adam is a recipient of the John Charles Polanyi Prize in Chemistry, recognizing the impact of his algorithms on the proteomics community. One of his publications was also recognized as the Highlight of the Year by an early career researcher at the HUPO World Congress. He is also Co-Chair of the HUPO Early Career Researcher Initiative.

Dr. Mathieu Lavallée-Adam

Click To Read Bio

Dr. Blandine Chazarin

Categories: Main Congress Speakers
Dr. Blandine Chazarin: United States

Postdoctoral scientist at ACBRI under supervision of Dr Jennifer Van Eyk. Working on clinical studies using mass spectrometry for plasma and remote sampling devices. Developing single cell proteomics approach to better understand cardiac diseases.

Dr. Blandine Chazarin

Click To Read Bio

Dr. Mehdi Bouhaddou

Categories: Main Congress Speakers
Dr. Mehdi Bouhaddou: United States

Dr. Mehdi (“Meh-Di”) Bouhaddou acquired his bachelor’s degree from the University of California, Berkeley and his PhD in Biomedical Sciences at the Mount Sinai School of Medicine. He is currently a National Cancer Institute postdoctoral fellow at the University of California, San Francisco (UCSF) advised by Dr. Nevan Krogan. Using both experimental and computational approaches, Mehdi specializes in integrating large biological datasets to understand how diseases, and potential therapies, can rewire cellular signaling. During his PhD, Mehdi developed mechanistic mathematical models of cancer signaling pathways, depicting their dynamical behavior in response to anti-cancer agents. He has since repurposed his skills in bioinformatics and molecular biology to study SARS-CoV-2 and other respiratory viruses of pandemic potential, with a specific focus on studying the functional effects of viral and host post-translational modifications (phosphorylation) that occur during infection.

Dr. Mehdi Bouhaddou

Click To Read Bio

Dr. Rob Rivers

Categories: Main Congress Speakers
Dr. Rob Rivers: United States

Rob Rivers, Ph.D. is a program director in the Office of Minority Health Research Coordination (OMHRC) at the National Institute of Diabetes, Digestive and Kidney Diseases, one of the Institutes that comprise the United States National Institutes of Health. He leads programs focused on increasing the biomedical research workforce’s diversity and expanding support in health disparities-related research. His doctoral research focused on studying intrinsically disordered proteins and their propensity to aggregate and their implications in disease. He earned a Ph.D. degree in Chemistry from the University of Cambridge and a B.S. degree in Chemistry from Kentucky State University.

Dr. Rob Rivers

Click To Read Bio

Prof. Chia-Jung Yu

Categories: Main Congress Speakers
Prof. Chia-Jung Yu: Taiwan

Chia-Jung Yu is a professor at the Department of Cell and Molecular Biology, Chang Gung University in Taiwan. Yu applies the integrative omics approach in clinical proteomics and molecular cell study. She works on the discovery and functional characterization of biomarkers in lung cancer progression and drug resistance. Her recent studies focus on the development of therapeutic targets and liquid biopsy to benefit lung cancer patients. Yu also investigates the function of Golgi-associated proteins for specific cellular functions in cancer cells. Yu is the director of the instrumentation center at Chang Gung University since 2016. She is active in the Taiwan Proteomics Society (TPS) and The Taiwan Society for Biochemistry and Molecular Biology (TSBMB). Her recent publication can be found in Clinical Cancer Research, Molecular & Cellular Proteomics, Journal of Proteome Research, Journal of Cell Science, and The FASEB Journal.

Prof. Chia-Jung Yu

Click To Read Bio

Dr. Ruth Hüttenhain

Categories: Main Congress Speakers
Dr. Ruth Hüttenhain: United States

Ruth Huttenhain is an Assistant Professor at the University of California, San Francisco (UCSF) in the Department of Cellular and Molecular Pharmacology. She obtained a Pharmacy degree from the University of Bonn and a PhD from ETH Zurich, Switzerland, where she developed high-throughput, large-scale targeted mass spectrometric approaches. During her postdoc at UCSF, Ruth extended her expertise in quantitative mass spectrometry to study dynamics of protein interaction networks. She pioneered a proximity labeling-mass spectrometry approach that simultaneously captures the precise temporal remodeling and spatial organization of proximal protein networks. The research of Ruth’s research group at UCSF focuses on characterizing protein interaction and signaling networks with spatiotemporal resolution to understand the biology underlying the development of psychiatric disorders and the sensing and transmission of pain. Ruth is Co-Chair of the HUPO Early Career Researcher (ECR) Initiative.

Dr. Ruth Hüttenhain

Click To Read Bio

Dr. Ling Hao

Categories: Main Congress Speakers
Dr. Ling Hao: United States

Dr. Ling Hao is an Assistant Professor of Chemistry at the George Washington University in Washington, D.C. She received her PhD from the University of Wisconsin-Madison, followed by postdoctoral training at the National Institutes of Health. She joined the faculty at GW since 2019, leading a research team and also teaching chemistry courses for both undergraduate and graduate students. She has co-authored 25 publications and served as a reviewer for 15 research journals and a guest editor for the Journal of Visualized Experiments. She received the ORAU Ralph E. Powe Junior Faculty Enhancement Award, GW University Facilitating Fund, and an NIH R01 grant to support her research in developing mass spectrometry-based strategies to study mitochondrial and lysosomal dysfunctions in neurodegenerative diseases. Hao Lab’s research is focused on developing proteomics, metabolomics, and proximity labeling techniques to understand the molecular mechanisms of neurological disorders and discover molecular biomarkers for brain diseases.

Dr. Ling Hao

Click To Read Bio

Dr. Aleksandra Nita-Lazar

Categories: Main Congress Speakers
Dr. Aleksandra Nita-Lazar: United States

Dr. Nita-Lazar received her Ph.D. in biochemistry in 2003 from the University of Basel for studies performed at the Friedrich Miescher Institute for Biomedical Research, where she studied protein glycosylation using mass spectrometry. After postdoctoral training at Stony Brook University and Massachusetts Institute of Technology, where she continued to investigate post-translational protein modifications and their influence on cell signaling, she joined the Program in Systems Immunology and Infectious Disease Research, now the Laboratory of Immune System Biology, in April 2009 as an Investigator and Chief of the Cellular Networks Proteomics Unit. In 2018 she became a tenured Senior Investigator and Chief of the Functional Cellular Networks Section.

Dr. Aleksandra Nita-Lazar

Click To Read Bio

Dr. Gary Kruppa

Categories: Main Congress Speakers
Dr. Gary Kruppa: Czech Republic

Gary Kruppa currently serves as the vice president for proteomics at Bruker Datlonics Inc. He manages a growing global team of applications and applications development scientists, focused on customer support and developing new proteomics applications. Dr. Kruppa earned his Ph. D. in chemical physics at CalTech. Dr. Kruppa has been working with Bruker since 1991 eventually serving as Vice President for FTMS. From 2001 to 2004 Dr. Kruppa ran his own research lab at Sandia National Labs, where he and his team developed novel methods and reagents for chemical crosslinking of proteins. From 2004 to 2014 he served as vice president for business development at Bruker. From 2014 to 2016 Dr. Kruppa served as CEO of MRM Proteomics Inc. Dr. Kruppa returned to Bruker in 2016 to serve as vice president for proteomics, where he helped launch the revolutionary timsTOF Pro QTOF mass spectrometer powered by the PASEF method.

Dr. Gary Kruppa

Click To Read Bio

Dr. Tiannan Guo

Categories: Main Congress Speakers
Dr. Tiannan Guo: China

Tiannan received training of clinical medicine (1999-2006) in Tongji Medical College, Huazhong University of Science and Technology, and learned biology (2001-2005) in Wuhan University, before he moved to Singapore for PhD training in cancer proteomics (2008-2012) in the laboratories of Dr. Newman Sze in Nanyang Technological University and Dr.Oi Lian Kon in National Cancer Centre Singapore. In 2012, Tiannan started his postdoctoral training in the laboratory of Dr. Ruedi Aebersold in ETH Zurich. Tiannan joined the Westlake University in August 2017 as a Tenure Track Assistant Professor. More in www.guomics.com.

Dr. Tiannan Guo

Click To Read Bio

Prof. Edouard Nice

Categories: Main Congress Speakers
Prof. Edouard Nice: Australia

Ed Nice is currently a Professor at Monash University where he is Head of Clinical Biomarker Discovery and Validation (Department of Biochemistry and Molecular Biology) and a scientific advisor to the Monash Antibody Technologies Facility (MATF), for which he was director from 2009 – 2013. He also holds a Visiting Professorship at Sichuan University/West China Hospital and an Adjunct Professor position at Macquarie University, Sydney, Australia. His long-term research interests have been in protein and peptide micropurification, biomarker discovery and validation, SPR analysis, high throughput monoclonal antibody production and validation, and clinical biomarker assay development, with a strong translational focus on colorectal cancer, especially the field of faecal proteomics for colorectal cancer detection and surveillance.

Prof. Edouard Nice

Click To Read Bio

Prof. Bernd Wollscheid

Categories: Main Congress Speakers
Prof. Bernd Wollscheid: Switzerland

Bernd Wollscheid is a Professor at the Institute of Translational Medicine at the Department of Health Sciences and Technology at the Federal Swiss Institute of Technology / ETH Zurich. Prof. Wollscheid is a chemical biologist who is spearheading a research team that develops, applies, and translates next-generation molecular health technologies to gain new insights into how molecular nanoscale organization influences biological function in health and disease. By using an array of technologies at the interface of Biology, Chemistry, Medicine, and Bioinformatics the Wollscheid laboratory strives to functionally understand the cellular surfaceome as a complex information/signaling gateway connecting the intracellular to the extracellular interactome. Wollscheidlab.org

Prof. Bernd Wollscheid

Click To Read Bio

Prof. Juri Rappsilber

Categories: Main Congress Speakers
Prof. Juri Rappsilber: Germany

Juri Rappsilber studied chemistry at the Technische Universität Berlin (Germany), Strathclyde University, Glasgow (UK) and with Tom Rapoport, Harvard Medical School, Boston (USA). In 2001, he earned his Ph.D. jointly from EMBL Heidelberg and the Johann Wolfgang Goethe University, Frankfurt (Germany) working in the laboratory of Matthias Mann on the mass spectrometric analysis of protein complexes. He completed a postdoctoral fellowship at the University of Southern Denmark, Odense before starting his independent career at IFOM, Milan (Italy) in 2003. In 2006, Juri joined the Wellcome Centre for Cell Biology, University of Edinburgh, twice obtaining Senior Research Fellowships of the Wellcome Trust and since 2010 being Professor of Proteomics. Since 2011, he is Professor of Bioanalytics at the Technische Universität Berlin. Juri combines organic chemistry and computational sciences with advanced mass spectrometry, to expand the frontiers of our understanding of the structural and mechanistic basis of how cells work.

Prof. Juri Rappsilber

Click To Read Bio

Prof. Catherine Wong

Categories: Main Congress Speakers
Prof. Catherine Wong: China

Professor Catherine C.L. Wong is the Director of Center for Precision Medicine Multi-omics Research (CPMMR), Associate Professor with Tenure at School of Basic Medical Sciences, Peking University Health Science Center, Principal Investigator at Peking University-Tsinghua University Center for Life Sciences (CLS), and Honorary Professor at the University of Manchester. She has been dedicating to the development of cutting-edge mass spectrometry-based proteomics technologies and the applications in basic biological and biomedical research. Moreover, to discover authentic disease biomarkers and to unveil disease mechanisms based on large clinical cohort were also her main pursuing. She used multi-omics technologies, combined with biotechnology, chemical biology, neural networks and other interdisciplinary technologies for functional verification, mechanism analysis, as well as clinical application of IVD. At present, multiple pipelines including tumors and mental diseases are in development and transformation. Professor Wong has published over 80 articles in the journals such as Cell, Science, Nature Methods, Nature Communications and so on.

Prof. Catherine Wong

Click To Read Bio

Prof. Bernhard Kuester

Categories: Main Congress Speakers
Prof. Bernhard Kuester: Germany

Bernhard is a chemist by training and holds a PhD in biochemistry from Oxford University. Before joining the Technical University of Munich (TUM) as a Full Professor of Proteomics , he was Vice President at Cellzome (now GSK). At TUM, he serves as the Director of the Bavarian Biomolecular Mass Spectrometry Center and Vice Dean Information Management of the School of Life Sciences. His research follows three major themes: i) mapping proteomes, ii) understanding how drugs work and iii) building ProteomeTools. The work of his team has been awarded the Discovery in Proteomic Sciences Award of HUPO and an ERC Advanced Grant. Bernhard is a Carl von Linde Senior Fellow of the TUM Institute for Advanced Study and was recently elected to the German National Academy of Science. Bernhard has co-founded two start-up companies that operate in the areas of proteomics and artificial intelligence.

Prof. Bernhard Kuester

Click To Read Bio

Dr. Renã Robinson

Categories: Main Congress Speakers
Dr. Renã Robinson: United States

Dr. Renã A. S. Robinson, Associate Professor of Chemistry at Vanderbilt University and inaugural Dorothy J. Wingfield Phillips Chancellor’s Faculty Fellow, received her B.S. in Chemistry with concentration in Business from the University of Louisville and Ph.D. in Analytical Chemistry from Indiana University under the mentorship of Professor David Clemmer. She developed proteomics methods to study aging in Drosophila and continued working in aging as a Lyman T. Johnson Postdoctoral Fellow with Professor D. Allan Butterfield (University of Kentucky). Focusing on neurodegenerative disorders such as Alzheimer’s disease, she received a UNCF/Merck Postdoctoral Fellowship. She joined the University of Pittsburgh as Assistant Professor (2009) and moved to Vanderbilt University (2017). She has an internationally recognized research program and is a leader in the field of proteomics for her work in aging, Alzheimer’s disease, and applications relevant to human health. Her laboratory focuses on using advancing proteomics and lipidomics technologies to further understanding of health disparities in Alzheimer’s disease.

Dr. Renã Robinson

Click To Read Bio

Prof. Stephen Pennington

Categories: Main Congress Speakers
Prof. Stephen Pennington: Ireland

Steve is Professor of Proteomics at University College Dublin, Ireland. A chemist (Imperial College, London) and PhD biochemist (University of Cambridge) by training, predominantly in human disease. Steve has been active, including roles as a committee member, in the British Society for Proteome Research for which he is currently President, the European Proteomics Association and is currently past-President of HUPO.

Prof. Stephen Pennington

Click To Read Bio

Dr. Jennifer Van Eyk

Categories: Main Congress Speakers
Dr. Jennifer Van Eyk: United States

Dr. Van Eyk is a Professor of Medicine at Cedars-Sinai Medical Center, Director of the Basic Science Research in the Barbra Streisand Woman’s Hearth Center and Director of the new Advance Clinical Biosystems Institute where she recently moved from Johns Hopkins University. Most recently she has become the co-director of the Cedars Sinai Precision Health, focused on in-hospital and population individualization of health care. Dr. Van Eyk is an international leader in the area of clinical proteomics and her lab has focused the developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. This includes multiple reaction monitoring (MRM, also known as SRM) and most recently data independent acquisition. Her laboratory is well known for the extreme technical quality of the data generated, rigorous quality control with tight %CV while applying these to key clinical questions. The aim is to maximize throughput and reproducibility in order to move targeted and robust discovery methods into large population healthy continuous assessment and clinical grade assays focusing on brain and cardiovascular diseases.

Dr. Jennifer Van Eyk

Click To Read Bio

Prof. Markus Ralser

Categories: Main Congress Speakers
Prof. Markus Ralser: Germany

Markus Ralser, Prof. Dr. Mag. (*1980), Einstein Professor of Biochemistry, is a leading scientist in the field of cellular metabolism and high-throughput mass spectrometry. His laboratory focuses on dissecting the biochemical and evolutionary logic of metabolism. He has made significant contributions in understanding how cellular metabolism is controlled at the scale of the genome, and how cells reconfigure metabolism to survive stress situations. The Ralser Lab is further known for its work in high throughput proteomics, a technological development driven by the need to understand metabolic networks in which hundreds of enzymes interact through interconverting an even higher number of metabolites. M. Ralser is currently the head of Charité’s Institute of Biochemistry, and a senior Group leader at the Francis Crick Institute in London. With a PhD background in Neuroscience, Markus started his independent scientific career as a Junior group leader at the Max Planck Institute for Molecular Genetics. In 2011, he then moved to the Cambridge Centre for Systems Biology and the Department of Biochemistry, University of Cambridge, and later, the Francis Crick Institute. Markus Ralser is the recipient of several notable science awards which included two ERC grants (Starting grant, Synergy grant), the Wellcome Beit Prize, the BioMed Central Research Award, the Colworth Medal of the Biochemical Society, the Starling Medal of the Endocrinological Society, and the EMBO Gold Medal. He is an EMBO Member.

Prof. Markus Ralser

Click To Read Bio

Prof. Emma Lundberg

Categories: Main Congress Speakers
Prof. Emma Lundberg: Sweden

Dr. Lundberg is Professor in Cell Biology Proteomics at KTH Royal Institute of Technology, Sweden, and Director of the Cell Atlas, of the Human Protein Atlas program. For this work she was recently top 10 under 40; future leaders in biopharma. Dr. Lundberg recently spent three sabbatical years as visiting Associate Professor at Stanford School of Medicine and the Chan-Zuckerberg Biohub. In the interface between bioimaging, proteomics and artificial intelligence her research aims to define the spatiotemporal proteome organization of human cells, to understand how variations in protein expression patterns contribute to cellular function and disease.

Prof. Emma Lundberg

Click To Read Bio

Prof. David Fenyo

Categories: Main Congress Speakers
Prof. David Fenyo: United States

Dr. David Fenyö received a PhD in Physics from Uppsala University in Sweden and after switching to computational biology, he did a postdoc at the Rockefeller University, co-founded a bioinformatics company and worked at GE Healthcare. He has over 30 years of experience with all aspects of biomedical data analysis in both academia and industry and his work has resulted in over 200 scientific publications. In 2010 he joined NYU School of Medicine where he is currently Professor of Biochemistry and Molecular Pharmacology, Director for the Ph.D. program in Systems and Computational Biomedicine and the Master’s program in Biomedical Informatics.. His research focuses on applying data science methods to analyze quantitative data and to model biological systems. His efforts to integrate data from multiple technologies—including mass spectrometry, sequencing, and microscopy—have provided a wide array of powerful tools to discover and verify biomarkers and therapeutic targets in cancer.

Prof. David Fenyo

Click To Read Bio

Prof. Ho Jeong Kwon

Categories: Main Congress Speakers
Prof. Ho Jeong Kwon: Republic of Korea

Professor Ho Jeong KWON graduated from Seoul National University (BSc, Korea) and did MS and PhD from University of Tokyo (Japan) and postdoctoral training at Harvard (USA). He returned to Korea in 1999 and promoted to full professor in 2008 at the department of biotechnology, Yonsei University. He has been director of chemical genomics Global Research Laboratory (GRL) program and serving as an adjunct professor, College of Medicine, Yonsei University and Lund University (Sweden) and SAC member of Institut Pasteur Korea. He has been serving as the president of AOHUPO (20-present) and served as a council member of HUPO (05-08, 15-17, 19-present), the president of KHUPO (10-11) and the president of Korean Society for Vascular Biology and Medicine (18-20). He has published over 220 papers in reputed journals (Google scholar citation; Total citation: 17,534, h-index: 50) and been serving as editor-in-chief of Proteome Science and editor of repute journals. He has also filed over 50 patents and received many awards including Doheon Biochemistry Award (KSBMB, 2020), Sura Academy Award (KMB, 2006) and Outstanding Research Professor Awards of Yonsei University (2011, 2013, 2016, 2017, 2018), Outstanding Teaching Award by Yonsei University (2008, 2013, 2020). His research interests focus on discovery of bioactive small molecules, target identification and validation, integration of omics technologies toward innovations in drug discovery and translational research.

Prof. Ho Jeong Kwon

Click To Read Bio

Prof. Yoshiya Oda

Position: Japan
Categories: Main Congress Speakers
Prof. Yoshiya Oda: Japan

Dr. Yoshiya Oda received his BS, MS and Ph.D. degree from Kyoto University. He worked in Eisai Pharma for 30 years. He also served as an associate professor at Medical Institute of Bioregulation in Kyushu University and Graduate School of Medicine at the University of Tokyo. He developed a widely used metabolic stable isotope labeling method for quantitative proteomics (PNAS 1999), phosphoproteomics (Nat. Biotech. 2001) and chemical proteomics (Anal. Chem. 2003). Dr. ODA has received Research Award from the Society of Chromatographic Sciences Japan (1999), Pharmaceutical Research Vision Award in the Pharmaceutical Society of Japan (2005), Research Award from the Mass Spectrometry Society of Japan (2005), Nature-Invitrogen Award (2006), and JHUPO Award from Japan Human Proteome Organization (2014). Dr. Oda is currently a professor at Graduate School of Medicine at the University of Tokyo, and a program officer for AMED-FORCE project at Japan Agency for Medical Research and Development.

Prof. Yoshiya Oda

Japan

Click To Read Bio

Prof. Tony Purcell

Categories: Main Congress Speakers
Prof. Tony Purcell: Australia

“Tony is an NHMRC Principal Research Fellow and Deputy Head of Australia’s largest Biochemistry Department at Monash University. He is the Vice President of the Australasian Proteomics Society, a HUPO council member and also serves as a Scientific Advisory Board Member of the Human Proteome Project.

His laboratory focusses on how the diverse array of peptides presented to the immune system (the immunopeptidome) is influenced by infection, inflammation and the environment. He has made important contributions to understanding the role of antigen presentation in several autoimmune diseases, drug hypersensitivity, cancer and infectious diseases. He is well known for work that has highlighted a role for post-translationally modified antigens in immunity. He is one of the most cited Australian proteomics researchers and a leader in the field of immunopeptidomics with over 230 related publications.”

Prof. Tony Purcell

Click To Read Bio

Dr. Steven Carr

Categories: Main Congress Speakers
Dr. Steven Carr: United States

Steve Carr is Director of Proteomics at the Broad Institute of MIT and Harvard. Steve and his group collaborate with scientists throughout the Broad Institute community to develop and apply state-of-the-art proteomics technology to address compelling questions in biology, chemistry, and clinical medicine. Research in his laboratory focuses on developing and applying new computational methods and mass spectrometry (MS)-based technologies to quantify proteins and their modifications and interaction partners in tissues, cells and biofluids with high sensitivity and specificity; improving informatics for peptide and protein identification by MS and integration of MS-derived data with genomic data to understand disease biology and drug effects. He is Deputy Editor of the journal Molecular and Cellular Proteomics and has >350 publications on the development and application of proteomics and biological MS. Prior to joining the Broad Institute in 2004, he held senior scientific leadership positions at GlaxoSmithKline and at Millennium Pharmaceuticals.

Dr. Steven Carr

Click To Read Bio

Dr. Juan Antonio Vizcaino

Categories: Main Congress Speakers
Dr. Juan Antonio Vizcaino: United Kingdom

“Dr. Juan Antonio Vizcaíno is the Proteomics Team Leader at the European Bioinformatics Institute (EMBL-EBI, Cambridge, UK). His team is responsible of the development of the PRIDE database, the world-leading public repository for mass spectrometry (MS) proteomics data (http://www.ebi.ac.uk/pride) and related tools and resources. In addition, he is coordinating the ProteomeXchange Consortium, aiming to standardize data submission and dissemination in proteomics resources worldwide. Over the years, he has heavily contributed to the development of many proteomics data standard formats (mzIdentML, mzQuantML, mzTab, proBed, proBAM, Universal Spectrum Identifiers) and related software, as part of his contribution to the HUPO Proteomics Standards Initiative (PSI).

He has been the leading author of highly-cited publications in journals such as Nature Biotechnology, Nature Methods, Nucleic Acids Research, Genome Biology and Molecular and Cellular Proteomics, among others. Overall, he has published ~130 articles with >17,000 citations (h-index=49, Google Scholar), largely in computational MS and bioinformatics.”

Dr. Juan Antonio Vizcaino

Click To Read Bio

Prof. Max Crispin

Categories: Main Congress Speakers
Prof. Max Crispin: United Kingdom

Max Crispin is Professor of Glycobiology at the University of Southampton where he leads the Glycoprotein Therapeutics Laboratory. He trained under Prof. Raymond Dwek and Prof. Pauline Rudd at the Oxford Glycobiology Institute, and Ian Wilson at The Scripps Research Institute. He did post-doctoral work in Oxford with Prof. Sir David Stuart and Prof. Yvonne Jones in the Division of Structural Biology, and then with Dr Chris Scanlan. His main area of research is in glycobiology and the structural biology of glycoproteins, and has current research programmes in therapeutic antibodies and viral glycobiology. Max is Professor Adjunct at Scripps Research and a Supernumerary Fellow of Oriel College, Oxford.

Prof. Max Crispin

Click To Read Bio

Sponsored Content